| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Adiponectin|ADIPOQ|ACDC|ACRP30|APM1|GBP28|30 kDa adipocyte complement-related protein|Adipocyte complement-related 30 kDa protein|ACRP30|Adipocyte, C1q and collagen domain-containing protein|Adipose most abundant gene transcript 1 protein |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human ADP (Adiponectin) (ADIPOQ) is a molecular target commonly studied in immunology, stem cells, and cardiovascular research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of ADP is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of ADP can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
ADP (Adiponectin) (ADIPOQ) may also be referenced as Adiponectin, ADIPOQ, and ACDC in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how ADP relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, stem cells, and cardiovascular research.
- Interpreting shifts in ADP levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
ADP has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, stem cells, and cardiovascular studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Genetic and Functional Effects of Adiponectin in Type 2 Diabetes Mellitus Development
IF: 6.208 Journal: International Journal of Molecular Sciences Cited Date: 2022-11-10
Association of adiponectin gene expression with atrial fibrillation in a Pakistani populace
IF: 4.6 Journal: Scientific Reports Author: Department of Zoology, Lahore College for Women University, Lahore, Pakistan Cited Date: 2023-12-29
The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial
IF: 4.3 Journal: Pharmaceuticals Author: First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece Cited Date: 2024-11-08
Is there any concern of insulin resistance and metabolic dysfunctions with antiseizure medications? A prospective comparative study of valproate vs. levetiracetam
IF: 2.7 Journal: Seizure: European Journal of Epilepsy Author: Dept. of Pharmacology, All India Institute of Medical Sciences, New Delhi, India Cited Date: 2024-08-09
Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis
IF: 2.631 Journal: Rheumatology International Cited Date: 2022-01-20
Obesity-Induced PVAT Dysfunction and Atherosclerosis Development: The Role of GHSR-1a in Increased Macrophage Infiltration and Adipocytokine Secretion
IF: 2.4 Journal: Journal of Cardiovascular Development and Disease Author: Department of Vascular Surgery, “Grigore T. Popa” University of Medicine and Pharmacy, 16, Universitatii Street, 700115 Iasi, Romania Cited Date: 2025-03-07
The Role of ADIPOQ and AMPK Signaling Pathway in Sarcopenia
IF: 2 Journal: International Journal of General Medicine Author: Department of First-Aid Center, Zhuzhou Central Hospital, Zhuzhou, Hunan, 412000, People’s Republic of China. Cited Date: 2025-08-15
Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension
IF: 1.894 Journal: Medical sicence monitor Cited Date: 2019-01-26
Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
IF: